Nye immunoterapier i lymfoide maligniteter.
Succesen med det anti-CD20 monoklonale antistof rituximab inden for afhjælpningen af lymfoide maligne sygdomme leverede et bevis-til-princip for udnyttelse af immunsystemet terapeutisk. Af den grund, at FDA-godkendelsen af rituximab i 1997, er der fremkommet en række nye metoder, der udnytter T-cellers fleksibilitet til at fokusere på de fleste kræftceller.
I betragtning af den lovende videnskabelige effektivitet af disse nye immunterapimetoder har FDA ikke for længe siden givet ‘gennembrud’ -betegnelse til et par nye lægemidler med forskellige mekanismer. For det første er kimærisk antigenreceptor (CAR) -T-celle-middel lovende for afhjælpningen af voksen og pædiatrisk tilbagefaldt og / eller ildfast akut lymfoblastisk leukæmi (ALL).
For det andet er blinatumomab, et bispecifikt T-celle engager (BiTE (®)) antistof, nu godkendt til afhjælpning af voksne med Philadelphia-kromosom-negativt tilbagefald og / eller ildfast B-forløber ALL. Til sidst bruges det monoklonale antistof nivolumab, der er målrettet mod PD-1-immun-checkpoint-receptoren med overdreven affinitet, til afhjælpning af Hodgkin-lymfom efter afhjælpningssvigt med autolog stamcelle-transplantation og brentuximab vedotin.

Heri vurderer vi baggrunden og forbedringen af disse tre forskellige immunterapiplatformer, beskæftiger os med de videnskabelige fremskridt med at forstå bevægelsesmekanismen for hvert middel og vurderer den nuværende videnskabelige information om deres effektivitet og sikkerhed. Vi taler desuden om fremtidige metoder til at forbedre disse immunoterapier ved forbedret teknik, valg af biomarkør og mekanismebaseret blandingsregime.
Bovine B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit |
|||
RDR-Bcl2-b-96Tests | Reddot Biotech | 96 Tests | EUR 859.2 |
B-Cell Leukemia / Lymphoma Protein |
|||
20-abx262315 | Abbexa |
|
|
Recombinant Human B-Cell Leukemia/Lymphoma 2 |
|||
7-04516 | CHI Scientific | 2µg | Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 |
|||
7-04517 | CHI Scientific | 10µg | Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 |
|||
7-04518 | CHI Scientific | 1mg | Ask for price |
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
|||
abx148562-100ug | Abbexa | 100 ug | EUR 526.8 |
B-Cell Leukemia/Lymphoma 2 (Bcl2) Antibody |
|||
20-abx171393 | Abbexa |
|
|
B-Cell Leukemia/Lymphoma 2 (Bcl2) Antibody |
|||
20-abx171394 | Abbexa |
|
|
B-Cell Leukemia/Lymphoma 2 (Bcl2) Antibody |
|||
20-abx171395 | Abbexa |
|
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
|||
20-abx136153 | Abbexa |
|
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
|||
20-abx137363 | Abbexa |
|
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
|||
abx139065-01mg | Abbexa | 0.1 mg | EUR 460.8 |
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
|||
20-abx133877 | Abbexa |
|
|
B-Cell Leukemia/Lymphoma 2 (Bcl2) Antibody |
|||
20-abx102594 | Abbexa |
|
|
B-Cell Leukemia/Lymphoma 2 (Bcl2) Antibody |
|||
20-abx102595 | Abbexa |
|
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
|||
abx038146-100ug | Abbexa | 100 ug | EUR 469.2 |
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
|||
20-abx000596 | Abbexa |
|
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
|||
20-abx009552 | Abbexa |
|
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
|||
20-abx121300 | Abbexa |
|
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
|||
20-abx121846 | Abbexa |
|
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
|||
20-abx125557 | Abbexa |
|
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
|||
20-abx125558 | Abbexa |
|
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
|||
20-abx109553 | Abbexa |
|
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
|||
20-abx111191 | Abbexa |
|
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
|||
abx012118-100ug | Abbexa | 100 ug | EUR 526.8 |
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
|||
abx012120-100ug | Abbexa | 100 ug | EUR 526.8 |
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
|||
abx016080-100ul | Abbexa | 100 ul | EUR 493.2 |
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
|||
abx018050-100ug | Abbexa | 100 ug | EUR 460.8 |
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
|||
abx019021-100ug | Abbexa | 100 ug | EUR 410.4 |
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
|||
abx020100-100ug | Abbexa | 100 ug | EUR 526.8 |
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
|||
abx034669-400ul | Abbexa | 400 ul | EUR 627.6 |
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
|||
abx034669-80l | Abbexa | 80 µl | EUR 343.2 |
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
|||
abx027629-400ul | Abbexa | 400 ul | EUR 627.6 |
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
|||
abx027629-80l | Abbexa | 80 µl | EUR 343.2 |
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
|||
abx031085-400ul | Abbexa | 400 ul | EUR 627.6 |
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
|||
abx031085-80l | Abbexa | 80 µl | EUR 343.2 |
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
|||
abx031231-400ul | Abbexa | 400 ul | EUR 627.6 |
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
|||
abx031231-80l | Abbexa | 80 µl | EUR 343.2 |
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
|||
20-abx330241 | Abbexa |
|
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
|||
abx330398-100ul | Abbexa | 100 ul | EUR 510 |
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
|||
abx330407-100ul | Abbexa | 100 ul | EUR 510 |
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
|||
abx230840-100ug | Abbexa | 100 ug | EUR 577.2 |
B-Cell Leukemia / Lymphoma 2 BH4 Protein |
|||
20-abx262301 | Abbexa |
|
|
B-Cell Leukemia / Lymphoma 2 BH1 Protein |
|||
20-abx262310 | Abbexa |
|
|
B-Cell Leukemia / Lymphoma 2 BH2 Protein |
|||
20-abx262311 | Abbexa |
|
|
B-Cell Leukemia / Lymphoma 2 BH3 Protein |
|||
20-abx262312 | Abbexa |
|
|
B-Cell Leukemia / Lymphoma 2 NWGR Protein |
|||
20-abx262313 | Abbexa |
|
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
|||
20-abx324769 | Abbexa |
|
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
|||
20-abx325066 | Abbexa |
|
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
|||
20-abx329156 | Abbexa |
|
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
|||
abx431122-200ul | Abbexa | 200 ul | EUR 460.8 |
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
|||
20-abx211156 | Abbexa |
|
|
B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody |
|||
20-abx211455 | Abbexa |
|
|
B-Cell Leukemia/Lymphoma 2 (Bcl2) Antibody |
|||
20-abx175544 | Abbexa |
|
|
B-Cell Leukemia/Lymphoma 2 (Bcl2) Antibody |
|||
20-abx175545 | Abbexa |
|
|
B-Cell Leukemia/Lymphoma 2 (Bcl2) Antibody |
|||
20-abx175546 | Abbexa |
|
|
B-Cell Leukemia/Lymphoma 2 (Bcl2) Antibody |
|||
20-abx175547 | Abbexa |
|
|
Recombinant B-Cell Leukemia/Lymphoma 2 (Bcl2) |
|||
4-RPA778Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human B-Cell Leukemia/Lymphoma 2 expressed in: E.coli |
Recombinant B-Cell Leukemia/Lymphoma 2 (Bcl2) |
|||
4-RPA778Mu01 | Cloud-Clone |
|
|
Description: Recombinant Mouse B-Cell Leukemia/Lymphoma 2 expressed in: E.coli |
Recombinant B-Cell Leukemia/Lymphoma 2 (Bcl2) |
|||
4-RPA778Ra01 | Cloud-Clone |
|
|
Description: Recombinant Rat B-Cell Leukemia/Lymphoma 2 expressed in: E.coli |
B-Cell Leukemia/Lymphoma 2 (Bcl-2) Antibody |
|||
abx019019-100ug | Abbexa | 100 ug | EUR 410.4 |
B-Cell Leukemia/Lymphoma 2 (Bcl-2) Antibody |
|||
abx413147-01mg | Abbexa | 0.1 mg | EUR 526.8 |
B-Cell Leukemia/Lymphoma 2 (Bcl-2) Antibody |
|||
abx448522-100ug | Abbexa | 100 ug | EUR 627.6 |
B-Cell Leukemia / Lymphoma XL Protein |
|||
20-abx260480 | Abbexa |
|
|
B-Cell Leukemia / Lymphoma XL Protein |
|||
20-abx260481 | Abbexa |
|
|
B-Cell Leukemia / Lymphoma XL Protein |
|||
20-abx262314 | Abbexa |
|
|
B-Cell Leukemia/Lymphoma Extra Large |
|||
PR27256 | Neuromics | 50 ug | EUR 381.6 |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH1 |
|||
7-04519 | CHI Scientific | 2µg | Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH1 |
|||
7-04520 | CHI Scientific | 10µg | Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH1 |
|||
7-04521 | CHI Scientific | 1mg | Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH2 |
|||
7-04522 | CHI Scientific | 2µg | Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH2 |
|||
7-04523 | CHI Scientific | 10µg | Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH2 |
|||
7-04524 | CHI Scientific | 1mg | Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH3 |
|||
7-04525 | CHI Scientific | 2µg | Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH3 |
|||
7-04526 | CHI Scientific | 10µg | Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH3 |
|||
7-04527 | CHI Scientific | 1mg | Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH4 |
|||
7-04528 | CHI Scientific | 2µg | Ask for price |
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH4 |
|||
7-04529 | CHI Scientific | 10µg | Ask for price |
Falsk leukæmi-lymfomcellestammer: en erstatning for over 500 cellestammer.
Humane leukæmi-lymfomceller (LL) -cellestammer betegner en særlig vigtig nyttig ressource til analyse inden for en hel del felter og discipliner. Fordi cellestammerne bruges som in vitro-mannequin-programmer i stedet for større cellematerialer, er det vigtigt, at cellerne inden for traditionskolberne trofast svarer til de påståede undersøgelsesgenstande.
- Det er klart, at korrekt godkendelse af cellelinjederivation og nøjagtig karakterisering er uundværlige nødvendigheder for at gøre brug af som mannequin-programmer. En hel del forskning har vist, at en uacceptabel fase af LL-cellestammer er falsk.
- Vi har lige her resultaterne af at autentificere et omfattende massivt mønster (n = 550) af LL-cellestammer primært ved DNA-fingeraftryk og cytogenetisk analyse.
- Overraskende er næsten identiske hændelser (ca. 15%) af falske cellestammer blevet bemærket blandt cellestammer, der blev opnået umiddelbart fra unikke efterforskere (59/395: 14,9%) og fra sekundære kilder (23/155: 14,8%), hvilket antyder, at næsten alle krydskontaminering udføres af ophavsmænd, formentlig i hele institutionen.
- Ved at evaluere vores information med disse afslørede har vi været yderligere i stand til at underklassificere de falske cellestammer som (1) digitale: krydskontamineret med og upålideligt overgroet af forskellige cellestammer under igangsætning, på ingen måde have det sjovt med uvildig eksistens; (2) forkert identificeret: krydskontamineret efter institutionen for at der stadig skulle være en unik prototype; eller (3) forkert klassificeret: uforvarende etableret fra en utilsigtet (typisk regelmæssig) celletype.
- Prolific basiske leukæmicelle-cellestammer er blevet opdaget for at tage højde for næsten alle krydskontaminationer, fx CCRF-CEM, HL-60, JURKAT, Ok-562 og U-937.
- Vi taler om påvirkningen af krydskontaminering på videnskabelig analyse, forskernes modvilje mod at tackle problemet og tage hensyn til mulige muligheder. Disse fund viser en begrundelse for mandat til anskaffelse af anerkendte LL-cellestammer og deres fælles godkendelse derefter.
Sammenlignende onkologi: hvad hjørnetænder og forskellige arter kan uddanne os om mennesker med flest kræftformer.
Over 1,66 millioner mennesker (ca. 500 / 100.000 indbyggere pris) og over 4,2 millioner hjørnetænder (ca. 5300 / 100.000 indbyggere pris) anerkendes med de fleste kræftformer årligt i USA. Det tværfaglige emne med komparativ onkologi præsenterer et nyt og kraftfuldt alternativ til at studere ekstra om de mest almindelige kræfttrusler og forbedringer ved epidemiologi, genetiske og genomiske undersøgelser.
Arbejdende gennem arter kan forskere fra human- og veterinærmedicinemedicin blande videnskabelige fund for at kende ekstra hurtigt oprindelsen af de fleste kræftformer og oversætte disse fund til nye terapier for at lære hvert menneske og dyr. Denne vurdering begynder med hjørnetændernes genetiske oprindelse og deres fordel i de fleste kræftanalyser.
Vi koncentrerer os efterfølgende om aktuelle fund i sammenlignende onkologi forbundet med arvelig eller genetisk trussel om tumorforbedring. Derefter elementerer vi de somatiske eller genomiske justeringer i tumorer og lighederne mellem arter.
De delte kræftformer mellem mennesker og hjørnetænder, som vi taler om, indbefatter sarkom (osteosarkom, delikat vævssarkom, histiocytisk sarkom, hæmangiosarkom), hæmatologiske maligniteter (lymfom, leukæmi), blære flest kræftformer, intrakraniel neoplasme (meningioma, glioma) og melanom.
Tumortrussel hos forskellige dyrearter kan også nævnes kort. Efterhånden som området inden for genomik udvikler sig, forudsiger vi, at sammenlignende onkologi vil fortsætte med at lære hvert enkelt folk og de dyr, der forbliver blandt os.
Bcl2 Associated Athanogene 3 (BAG3) Antibody |
|||
20-abx007802 | Abbexa |
|
|
Bcl2 Associated Athanogene 3 (BAG3) Antibody |
|||
abx122188-100ug | Abbexa | 100 ug | EUR 469.2 |
Bcl2 Associated Athanogene 3 (BAG3) Antibody |
|||
20-abx109563 | Abbexa |
|
|
Bcl2 Associated Athanogene 3 (BAG3) Antibody |
|||
20-abx111206 | Abbexa |
|
|
Bcl2 Associated Athanogene 3 (BAG3) Antibody |
|||
20-abx015148 | Abbexa |
|
|
Bcl2 Associated Athanogene 3 (BAG3) Antibody |
|||
20-abx323328 | Abbexa |
|
|
Bcl2 Associated Athanogene 3 (BAG3) Antibody |
|||
abx330596-100ul | Abbexa | 100 ul | EUR 510 |
Bcl2 Associated Athanogene 3 (BAG3) Antibody |
|||
abx230789-100ug | Abbexa | 100 ug | EUR 577.2 |
Bcl2 Associated Athanogene 3 (BAG3) Antibody |
|||
20-abx328816 | Abbexa |
|
|
Bcl2 Associated Athanogene 3 (BAG3) Antibody |
|||
abx430195-200ul | Abbexa | 200 ul | EUR 460.8 |
Bcl2 Associated Athanogene 3 (BAG3) Antibody |
|||
abx432392-200ul | Abbexa | 200 ul | EUR 460.8 |
Bcl2 Associated Athanogene 3 (BAG3) Antibody |
|||
20-abx212138 | Abbexa |
|
|
Bcl2 Associated Athanogene 3 (BAG3) Antibody |
|||
20-abx213157 | Abbexa |
|
|
Bcl2 Associated Athanogene 3 (BAG3) Antibody |
|||
20-abx175551 | Abbexa |
|
|
Human Bcl2 Associated Athanogene 3 (BAG3) Protein |
|||
20-abx652649 | Abbexa |
|
|
BCL2-Associated Athanogene 1 Protein |
|||
20-abx260589 | Abbexa |
|
|
BCL2-Associated Athanogene 2 Protein |
|||
20-abx261156 | Abbexa |
|
|
Recombinant Human BCL2-Associated Athanogene 1 |
|||
7-04474 | CHI Scientific | 5µg | Ask for price |
Recombinant Human BCL2-Associated Athanogene 1 |
|||
7-04475 | CHI Scientific | 20µg | Ask for price |
Recombinant Human BCL2-Associated Athanogene 1 |
|||
7-04476 | CHI Scientific | 1mg | Ask for price |
Recombinant Human BCL2-Associated Athanogene 2 |
|||
7-04477 | CHI Scientific | 5µg | Ask for price |
Recombinant Human BCL2-Associated Athanogene 2 |
|||
7-04478 | CHI Scientific | 20µg | Ask for price |
Recombinant Human BCL2-Associated Athanogene 2 |
|||
7-04479 | CHI Scientific | 1mg | Ask for price |
Bcl2 Associated Athanogene 3 (BAG3) Antibody (Biotin) |
|||
20-abx105175 | Abbexa |
|
|
Bcl2 Associated Athanogene 3 (BAG3) Antibody (FITC) |
|||
20-abx106592 | Abbexa |
|
|
Bcl2 Associated Athanogene 3 (BAG3) Antibody (HRP) |
|||
20-abx108009 | Abbexa |
|
|
Human Bcl2 Associated Athanogene 3 (BAG3) ELISA Kit |
|||
20-abx150783 | Abbexa |
|
|
Human Bcl2 Associated Athanogene 3 (BAG3) ELISA Kit |
|||
abx252067-96tests | Abbexa | 96 tests | EUR 848.4 |
Human Bcl2 Associated Athanogene 3 (BAG3) CLIA Kit |
|||
20-abx493623 | Abbexa |
|
|
Human Bcl2 Associated Athanogene 3 (BAG3) CLIA Kit |
|||
abx195225-96tests | Abbexa | 96 tests | EUR 990 |
Human Bcl2 Associated Athanogene 3 (BAG3) ELISA Kit |
|||
DLR-BAG3-Hu-48T | DL Develop | 48T | EUR 620.4 |
Description: A sandwich quantitative ELISA assay kit for detection of Human Bcl2 Associated Athanogene 3 (BAG3) in samples from serum, plasma, tissue homogenates, cell lysates or other biological fluids. |
Human Bcl2 Associated Athanogene 3 (BAG3) ELISA Kit |
|||
DLR-BAG3-Hu-96T | DL Develop | 96T | EUR 807.6 |
Description: A sandwich quantitative ELISA assay kit for detection of Human Bcl2 Associated Athanogene 3 (BAG3) in samples from serum, plasma, tissue homogenates, cell lysates or other biological fluids. |
Human BAG3(Bcl2 Associated Athanogene 3) ELISA Kit |
|||
EH2689 | FN Test | 96T | EUR 628.92 |
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 0.094 ng/ml |
BAG3 BCL2-Associated Athanogene 3 Human Recombinant Protein |
|||
PROTO95817 | BosterBio | Regular: 10ug | EUR 380.4 |
Description: BAG3 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 595 amino acids (1-575 a.a.) and having a molecular mass of 63.7 kDa. The BAG3 protein is fused to a 20 amino acid His Tag at N-terminus and purified by standard chromatogrpahy techniques. |
Human Bcl2 Associated Athanogene 3 (BAG3) ELISA Kit |
|||
RD-BAG3-Hu-48Tests | Reddot Biotech | 48 Tests | EUR 625.2 |
Human Bcl2 Associated Athanogene 3 (BAG3) ELISA Kit |
|||
RD-BAG3-Hu-96Tests | Reddot Biotech | 96 Tests | EUR 867.6 |
Human Bcl2 Associated Athanogene 3 (BAG3) ELISA Kit |
|||
SEC335Hu-10x96wellstestplate | Cloud-Clone | 10x96-wells test plate | EUR 5677.8 |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Bcl2 Associated Athanogene 3 (BAG3) in serum, plasma, tissue homogenates, cell lysates and other biological fluids. |
Human Bcl2 Associated Athanogene 3 (BAG3) ELISA Kit |
|||
SEC335Hu-1x48wellstestplate | Cloud-Clone | 1x48-wells test plate | EUR 572.76 |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Bcl2 Associated Athanogene 3 (BAG3) in serum, plasma, tissue homogenates, cell lysates and other biological fluids. |
Human Bcl2 Associated Athanogene 3 (BAG3) ELISA Kit |
|||
SEC335Hu-1x96wellstestplate | Cloud-Clone | 1x96-wells test plate | EUR 766.8 |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Bcl2 Associated Athanogene 3 (BAG3) in serum, plasma, tissue homogenates, cell lysates and other biological fluids. |
Human Bcl2 Associated Athanogene 3 (BAG3) ELISA Kit |
|||
SEC335Hu-5x96wellstestplate | Cloud-Clone | 5x96-wells test plate | EUR 3090.6 |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Bcl2 Associated Athanogene 3 (BAG3) in serum, plasma, tissue homogenates, cell lysates and other biological fluids. |
Human Bcl2 Associated Athanogene 3 (BAG3) ELISA Kit |
|||
4-SEC335Hu | Cloud-Clone |
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Bcl2 Associated Athanogene 3 (BAG3) in samples from serum, plasma, tissue homogenates, cell lysates and other biological fluids with no significant corss-reactivity with analogues from other species. |
Human Bcl2 Associated Athanogene 3 (BAG3) ELISA Kit |
|||
RDR-BAG3-Hu-48Tests | Reddot Biotech | 48 Tests | EUR 652.8 |
Human Bcl2 Associated Athanogene 3 (BAG3) ELISA Kit |
|||
RDR-BAG3-Hu-96Tests | Reddot Biotech | 96 Tests | EUR 907.2 |
Human Bcl2 Associated Athanogene 3(BAG3) ELISA Kit |
|||
QY-E05117 | Qayee Biotechnology | 96T | EUR 480 |
BCL2 Associated Athanogene 1 (BAG1) Antibody |
|||
20-abx001023 | Abbexa |
|
|
Bcl2 Associated Athanogene 4 (BAG4) Antibody |
|||
20-abx008411 | Abbexa |
|
|
BCL2 Associated Athanogene 1 (BAG1) Antibody |
|||
20-abx121295 | Abbexa |
|
|
Bcl2 Associated Athanogene 4 (BAG4) Antibody |
|||
20-abx124475 | Abbexa |
|
|
BCL2 Associated Athanogene 1 (BAG1) Antibody |
|||
abx117033-100ug | Abbexa | 100 ug | EUR 560.4 |
Bcl2 Associated Athanogene 1 (BAG1) Antibody |
|||
20-abx111205 | Abbexa |
|
|
Bcl2 Associated Athanogene 4 (BAG4) Antibody |
|||
20-abx111207 | Abbexa |
|
|
Bcl2 Associated Athanogene 4 (BAG4) Antibody |
|||
20-abx015149 | Abbexa |
|
|
Bcl2 Associated Athanogene 4 (BAG4) Antibody |
|||
abx028746-400ul | Abbexa | 400 ul | EUR 627.6 |
Bcl2 Associated Athanogene 4 (BAG4) Antibody |
|||
abx028746-80l | Abbexa | 80 µl | EUR 343.2 |
BCL2 Associated Athanogene 1 (BAG1) Antibody |
|||
abx031785-400ul | Abbexa | 400 ul | EUR 627.6 |
BCL2 Associated Athanogene 1 (BAG1) Antibody |
|||
abx031785-80l | Abbexa | 80 µl | EUR 343.2 |
BCL2 Associated Athanogene 1 (BAG1) Antibody |
|||
abx036106-100ug | Abbexa | 100 ug | EUR 469.2 |
Bcl2 Associated Athanogene 4 (BAG4) Antibody |
|||
abx332525-100ul | Abbexa | 100 ul | EUR 510 |
Bcl2 Associated Athanogene 4 (BAG4) Antibody |
|||
20-abx302239 | Abbexa |
|
|
Bcl2 Associated Athanogene 1 (BAG1) Antibody |
|||
20-abx323620 | Abbexa |
|
|
Bcl2 Associated Athanogene 4 (BAG4) Antibody |
|||
20-abx328774 | Abbexa |
|
|
Bcl2 Associated Athanogene 1 (BAG1) Antibody |
|||
20-abx211126 | Abbexa |
|
|
Bcl2 Associated Athanogene 1 (BAG1) Antibody |
|||
20-abx211212 | Abbexa |
|
|
Bcl2 Associated Athanogene 4 (BAG4) Antibody |
|||
20-abx212050 | Abbexa |
|
|
Bcl2 Associated Athanogene 4 (BAG4) Antibody |
|||
20-abx212051 | Abbexa |
|
|
Bcl2 Associated Athanogene 1 (BAG1) Antibody |
|||
20-abx175549 | Abbexa |
|
|
Bcl2 Associated Athanogene 1 (BAG1) Antibody |
|||
20-abx175550 | Abbexa |
|
|
Bcl2 Associated Athanogene 4 (BAG4) Antibody |
|||
20-abx175552 | Abbexa |
|
|
Recombinant Bcl2 Associated Athanogene 5 (BAG5) |
|||
4-RPF225Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human Bcl2 Associated Athanogene 5 expressed in: E.coli |
Recombinant Bcl2 Associated Athanogene 5 (BAG5) |
|||
4-RPF225Mu01 | Cloud-Clone |
|
|
Description: Recombinant Mouse Bcl2 Associated Athanogene 5 expressed in: E.coli |
Recombinant Bcl2 Associated Athanogene 5 (BAG5) |
|||
4-RPF225Ra01 | Cloud-Clone |
|
|
Description: Recombinant Rat Bcl2 Associated Athanogene 5 expressed in: E.coli |
Recombinant Bcl2 Associated Athanogene 4 (BAG4) |
|||
4-RPF226Mu01 | Cloud-Clone |
|
|
Description: Recombinant Mouse Bcl2 Associated Athanogene 4 expressed in: E.coli |
Recombinant Bcl2 Associated Athanogene 1 (BAG1) |
|||
4-RPF228Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human Bcl2 Associated Athanogene 1 expressed in: E.coli |
Recombinant Bcl2 Associated Athanogene 1 (BAG1) |
|||
4-RPF228Mu01 | Cloud-Clone |
|
|
Description: Recombinant Mouse Bcl2 Associated Athanogene 1 expressed in: E.coli |
Recombinant Bcl2 Associated Athanogene 1 (BAG1) |
|||
4-RPF228Ra01 | Cloud-Clone |
|
|
Description: Recombinant Rat Bcl2 Associated Athanogene 1 expressed in: E.coli |
Human Bcl2 Associated Athanogene 1 (BAG1) Protein |
|||
20-abx650651 | Abbexa |
|
|
Monkey Bcl2 Associated Athanogene 3 (BAG3) ELISA Kit |
|||
abx358801-96tests | Abbexa | 96 tests | EUR 990 |
Pig Bcl2 Associated Athanogene 3 (BAG3) ELISA Kit |
|||
abx360578-96tests | Abbexa | 96 tests | EUR 990 |
Rabbit Bcl2 Associated Athanogene 3 (BAG3) ELISA Kit |
|||
abx363609-96tests | Abbexa | 96 tests | EUR 990 |
Chicken Bcl2 Associated Athanogene 3 (BAG3) ELISA Kit |
|||
abx355517-96tests | Abbexa | 96 tests | EUR 990 |
CLIA kit for Human BAG3 (Bcl2 Associated Athanogene 3) |
|||
E-CL-H0338 | Elabscience Biotech | 1 plate of 96 wells | EUR 700.8 |
Description: A sandwich CLIA kit for quantitative measurement of Human BAG3 (Bcl2 Associated Athanogene 3) in samples from Serum, Plasma, Cell supernatant |
ELISA kit for Human BAG3 (Bcl2 Associated Athanogene 3) |
|||
E-EL-H0418 | Elabscience Biotech | 1 plate of 96 wells | EUR 640.8 |
Description: A sandwich ELISA kit for quantitative measurement of Human BAG3 (Bcl2 Associated Athanogene 3) in samples from Serum, Plasma, Cell supernatant |
ELISA kit for Human BAG3 (Bcl2 Associated Athanogene 3) |
|||
ELK3699 | ELK Biotech | 1 plate of 96 wells | EUR 518.4 |
Description: A sandwich ELISA kit for detection of Bcl2 Associated Athanogene 3 from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |